Podcast 136: Aspirin lowers colorectal risks in Lynch syndrome — what are the implications for everyone else?

Last week’s Lancet article on the effect of aspirin on risks for colorectal cancer in patients with Lynch syndrome — a group at particularly high risk — may hold implications for preventing sporadic colon cancers.

Our interview with Prof. Sir John Burn, the study’s first author, explores those implications as well speculations on why  we human beings aren’t getting the salicylates we were when our vegetables weren’t so pampered.

Links:

• Physician’s First Watch coverge (free)
• Lancet abstract (free)
• NEJM 2008 paper (free)
• The CAPP3 website

The post Podcast 136: Aspirin lowers colorectal risks in Lynch syndrome — what are the implications for everyone else? first appeared on Clinical Conversations.